Pulmonary Hypertension Group Hears New Treatment Updates
A Kettering support group marked PH Awareness Month with a guest speaker from UC Health discussing medications and upcoming trials.
Updated on Nov. 21, 2026 in Heart Disease

The Pulmonary Hypertension Warriors Support Group celebrated PH Awareness Month with a guest speaker at South Dayton Presbyterian Church in Kettering on November 14, 2026. Dr. Jean Elwing of UC Health presented information on new medications being developed and upcoming trials for Pulmonary Arterial Hypertension patients.
Why it matters
Pulmonary Arterial Hypertension is often unknown to the public, according to support group leader Mary Hale, so awareness events help patients and families learn about available options. Trials are structured for different patient groups based on the medications they take, which may affect who can participate.
The source does not provide specific efficacy percentages, sample sizes or study durations for the medications or trials discussed. Details on which patient groups qualify for each trial remain unspecified.
The players
UC Health
UC Health is a academic health system based in Cincinnati, Ohio, affiliated with the University of Cincinnati and operating hospitals and clinics across the region.
Dr. Jean Elwing
Dr. Jean Elwing is a physician affiliated with UC Health who presented information on pulmonary hypertension medications and clinical trials at the event.
The details
Attendees heard from Dr. Jean Elwing of UC Health about new medications under development and upcoming trials available to patients depending on their current treatment. Support group leader Mary Hale noted that not everyone who uses oxygen has COPD, highlighting that PH is frequently misunderstood.
Timeline
November 14, 2026: PH Awareness Month event held at South Dayton Presbyterian Church in Kettering.
Clinical Research Context
The trials discussed follow a pattern of stratifying Pulmonary Arterial Hypertension patients by the medications they already take, a design that allows newer therapies to be tested in defined patient groups. This local update reflects how such multi-arm trial structures are being communicated to patients outside academic centers.
Patients with Pulmonary Arterial Hypertension may be able to ask their care team whether they qualify for upcoming trials based on their current medications. Support groups provide a practical place to learn which studies are recruiting.
The takeaway
Patients living with pulmonary hypertension should ask their physicians whether their current medications place them in an eligible group for upcoming trials. Local support groups can help connect people with current research information.
Further reading
For more background, explore Heart Disease coverage on Wisevoter.
Source note: This article includes information reported by WDTN.






